PALISADE CAPITAL MANAGEMENT, LP Q2 2022 Filing

Filed August 10, 2022

Portfolio Value

$3.7T

Holdings

422

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (422 positions)

#StockSharesValue% PortfolioType
401
QDELQUIDELORTHO CORP
3,000$292.0M0.01%
402
THERAVANCE BIOPHARMA INC
308,000$286.0M0.01%
403
GMGENERAL MTRS CO
8,800$279.0M0.01%
404
ACNACCENTURE PLC IRELAND
957$266.0M0.01%
405
BKNGBOOKING HOLDINGS INC
140$245.0M0.01%
406
LLYLILLY ELI & CO
745$242.0M0.01%
407
SUPERNUS PHARMACEUTICALS
238,000$231.0M0.01%
408
MUMICRON TECHNOLOGY INC
4,050$224.0M0.01%
409
APOLLO COML REAL ESTATE FIN
220,000$216.0M0.01%
410
RSPINVESCO EXCHANGE TRADED FD T
1,602$215.0M0.01%
411
RBBNRIBBON COMMUNICATIONS INC
70,000$213.0M0.01%
412
BLNKBLINK CHARGING CO
10,000$165.0M0.00%
413
HOODROBINHOOD MKTS INC
20,000$164.0M0.00%
414
MITKMITEK SYS INC
16,000$148.0M0.00%
415
LYFTLYFT INC
10,200$135.0M0.00%
416
AALAMERICAN AIRLS GROUP INC
10,500$133.0M0.00%
417
BRICKELL BIOTECH INC
970,547$122.0M0.00%
418
GOEVQCANOO INC
40,000$74.0M0.00%
419
CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC
80,000$55.0M0.00%
420
SYNCHRONOSS TECHNOLOGIES INC
35,000$40.0M0.00%
421
MANDIANT INC
15,000$14.0M0.00%
422
PALATIN TECHNOLOGIES INC
19,010$5.0M0.00%
PreviousPage 5 of 5